Angiocrine Announces Presentation of AB-205 Trial Data during ASTCT and CIBMTR
13 Feb 2023 //
PR NEWSWIRE
Angiocrine has been awarded a $15M Grant for AB-205 Phase 3 Clinical Trial
19 Dec 2022 //
PRNEWSWIRE
Angiocrine Bioscience Announces Presentation of AB-205 Trial during Meeting
09 Dec 2022 //
BIONJ
Angiocrine Bio Begins Dosing in Pivotal Phase 3 Clinical Trial of AB-205
29 Mar 2022 //
PRNEWSWIRE
Angiocrine Bioscience Announces Oral Presentation of AB-205 Data during the 47th
12 Mar 2021 //
PRNEWSWIRE
Angiocrine Bioscience Announces Oral Presentation of AB-205 Data
11 Mar 2021 //
PRNEWSWIRE
Angiocrine Bioscience Announces Oral Presentation of Intravenous AB-205 Data
05 Feb 2021 //
PRNEWSWIRE
Angiocrine Bioscience Announces Oral Presentation of AB-205 Data
04 Dec 2020 //
PRNEWSWIRE

Market Place
Sourcing Support